Product Code: 978-1-68038-502-1
Compression Therapy Market Summary
The global compression therapy market size was estimated at USD 4.43 billion in 2025 and is projected to reach USD 5.88 billion by 2033, growing at a CAGR of 3.54% from 2026 to 2033, driven by the rising prevalence of venous and lymphatic disorders such as Deep Vein Thrombosis (DVT), varicose veins, lymphedema, and chronic venous insufficiency. Compression therapy, which applies controlled pressure to improve blood circulation and reduce swelling, has become an essential solution for both prevention and treatment of these conditions.
Growth is further fueled by the increasing burden of chronic diseases such as obesity, diabetes, and cardiovascular conditions, along with a rapidly aging global population that is more susceptible to circulatory disorders. In addition, the rising number of surgical procedures and sports-related injuries is boosting demand for compression therapy in post-operative care and rehabilitation.
The rising prevalence of Deep Vein Thrombosis (DVT) is significantly growing the compression therapy market, as the condition requires effective prevention and management strategies to reduce complications. DVT, which involves the formation of blood clots in deep veins primarily in the legs, is becoming more common due to factors such as sedentary lifestyles, increasing obesity rates, an aging population, and a higher number of surgical procedures. Compression therapy, including stockings and pneumatic devices, is widely recommended to improve blood circulation, prevent clot formation, and reduce the risk of post-thrombotic complications.
- According to the Centers for Disease Control and Prevention (CDC) data from 2025, up to 900,000 people in the U.S. are affected by venous thromboembolism (VTE) each year, highlighting the significant burden of this condition on the healthcare system.
Conditions such as chronic venous insufficiency and venous ulcers impact many people worldwide, with factors such as aging populations, inactive lifestyles, and obesity playing a major role. Compression therapy for venous ulcers is highly effective; therefore, the rising prevalence of venous ulcers will drive market growth in the near future. Moreover, compression therapy for varicose veins is a highly effective treatment compared to other options. For instance, data from the Society for Vascular Surgery indicate that as many as 40 million Americans have varicose veins. Moreover, according to an article published by NCBI, around 150,000 new cases of chronic venous insufficiency are diagnosed each year, with approximately USD 500 million spent on the care of these patients.
Compression therapy works by applying controlled pressure to the affected limbs, helping ease symptoms, enhance blood flow, reduce swelling, and aid healing, while preventing complications. Thus, the growing awareness of compression therapy's effectiveness in managing chronic venous conditions is expected to drive market growth.
The growing number of orthopedic procedures is driving an increased need for compression therapy as part of postoperative care and rehabilitation protocols. Orthopedic surgeries, including joint replacements (such as knee or hip replacements), fracture repairs, ligament reconstructions, and arthroscopic surgeries, are becoming more common due to factors such as an aging population, sports-related injuries, and advancements in surgical techniques. For instance, according to data from the American College of Rheumatology, the number of knee and hip replacements performed annually in the U.S. is on the rise due to the aging population, with approximately 790,000 knee replacements and 544,000 hip replacements performed each year. According to data published by the Australian Orthopedic Association National Joint Replacement Registry (AOANJRR) in 2024, more than 2.1 million orthopedic procedures were performed in Australia.
After an orthopedic procedure, patients commonly experience swelling, inflammation, and reduced mobility in the operated limbs. Compression therapy plays a vital role in managing these postoperative symptoms and in providing recovery by improving blood circulation, reducing swelling, and supporting the surgical site.
The increasing cases of obesity have led to an increase in the adoption of compression therapy as a crucial device in managing health-related concerns. Obesity, characterized by excessive body fat accumulation, not only increases the risk of chronic disorders such as CVD, diabetes, & hypertension but also contributes to venous insufficiency and associated disorders. For instance, an article published in the International Journal of Medical Science and Clinical Invention suggests that obesity increases the risk of venous insufficiency and associated complications by more than sixfold. As per the World Obesity Federation, in 2024, more than one billion people worldwide were living with obesity, which is about one in eight people. This includes nearly 880 million adults, and 159 million children and adolescents aged 5-19. The World Obesity Federation's 2025 Atlas, published on World Obesity Day (4 March), projects that the total number of adults living with obesity will increase by more than 115% between 2010 and 2030, from 524 million to 1.13 billion.
Global Compression Therapy Market Report Segmentation
This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the compression therapy market report based on technology, end use, distribution channel, and region.
- Technology Outlook (Revenue, USD Million, 2021 - 2033)
- Static Compression Therapy
- Compression Bandages
- Compression Stockings
- Compression Tape
- Others Compression Garments
- Dynamic Compression Therapy
- Compression Pumps
- Compression Sleeves
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Home Healthcare
- Physician's Office
- Nursing Homes
- Others
- Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Institutional Sales
- Retail Sales
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Compression Therapy Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Ancillary Market Outlook
- 3.1.2. Parent Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing prevalence of chronic vein disorders
- 3.2.1.2. Growing number of orthopedic procedures
- 3.2.1.3. Growing Incidence of obesity
- 3.2.1.4. Growing aging population
- 3.2.1.5. Rising awareness about non-invasive treatment options
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Alternative treatment method
- 3.2.2.2. Lack of awareness in rural and underdeveloped regions
- 3.2.3. Market Opportunities Analysis
- 3.2.3.1. Increasing adoption of home-based treatment solutions
- 3.2.3.2. Technological advancements
- 3.2.3.3. Growing demand in emerging markets
- 3.2.3.4. Expansion of e-commerce and retail distribution channels
- 3.2.3.5. Untapped rural healthcare markets
- 3.2.4. Market Challenge Analysis
- 3.2.4.1. Patient discomfort and compliance issues
- 3.2.4.2. Limited reimbursement policies in developing regions
- 3.3. Compression Therapy Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal Landscape
- 3.3.2.2. Economic and Social Landscape
- 3.3.2.3. Technological landscape
Chapter 4. Compression Therapy Market: Technology Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Compression Therapy Market Movement Analysis
- 4.3. Global Compression Therapy Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
- 4.4. Static Compression Therapy
- 4.4.1. Static Compression Therapy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.1.1. Compression Bandages
- 4.4.1.1.1. Compression Bandages Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.1.2. Compression Stockings
- 4.4.1.2.1. Compression Stockings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.1.3. Compression Tape
- 4.4.1.3.1. Compression Tape Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.1.4. Other Compression Garments
- 4.4.1.4.1. Other Compression Garments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5. Dynamic Compression Therapy
- 4.5.1. Dynamic Compression Therapy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.1.1. Compression Pumps
- 4.5.1.1.1. Compression Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.1.2. Compression Sleeves
- 4.5.1.2.1. Compression Sleeves Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Compression Therapy Market: End Use Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Compression Therapy Market Movement Analysis
- 5.3. Global Compression Therapy Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 5.4. Hospitals
- 5.4.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. Specialty Clinics
- 5.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. Home Healthcare
- 5.6.1. Home Healthcare Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. Physician's Office
- 5.7.1. Physician's Office Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.8. Nursing Homes
- 5.8.1. Nursing Homes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.9. Others
- 5.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Compression Therapy Market: Distribution Channel Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Compression Therapy Market Movement Analysis
- 6.3. Global Compression Therapy Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
- 6.4. Institutional Sales
- 6.4.1. Institutional Sales Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Retail Sales
- 6.5.1. Retail Sales Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Compression Therapy Market: Regional Estimates & Trend Analysis By Technology, By End Use, By Distribution Channel
- 7.1. Regional Dashboard
- 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
- 7.3. North America
- 7.3.1. North America Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Competitive Scenario
- 7.3.2.3. Regulatory Scenario
- 7.3.2.4. Reimbursement Scenario
- 7.3.2.5. U.S. Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Competitive Scenario
- 7.3.3.3. Regulatory Scenario
- 7.3.3.4. Reimbursement Scenario
- 7.3.3.5. Canada Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Competitive Scenario
- 7.3.4.3. Regulatory Scenario
- 7.3.4.4. Reimbursement Scenario
- 7.3.4.5. Mexico Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4. Europe
- 7.4.1. Europe Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.2. UK
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Regulatory Scenario
- 7.4.2.4. Reimbursement Scenario
- 7.4.2.5. UK Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.3. Germany
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Regulatory Scenario
- 7.4.3.4. Reimbursement Scenario
- 7.4.3.5. Germany Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. Regulatory Scenario
- 7.4.4.4. Reimbursement Scenario
- 7.4.4.5. France Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Competitive Scenario
- 7.4.5.3. Regulatory Scenario
- 7.4.5.4. Reimbursement Scenario
- 7.4.5.5. Italy Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Competitive Scenario
- 7.4.6.3. Regulatory Scenario
- 7.4.6.4. Reimbursement Scenario
- 7.4.6.5. Spain Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.7. Denmark
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Competitive Scenario
- 7.4.7.3. Regulatory Scenario
- 7.4.7.4. Reimbursement Scenario
- 7.4.7.5. Denmark Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.8. Sweden
- 7.4.8.1. Key Country Dynamics
- 7.4.8.2. Competitive Scenario
- 7.4.8.3. Regulatory Scenario
- 7.4.8.4. Reimbursement Scenario
- 7.4.8.5. Sweden Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.9. Norway
- 7.4.9.1. Key Country Dynamics
- 7.4.9.2. Competitive Scenario
- 7.4.9.3. Regulatory Scenario
- 7.4.9.4. Reimbursement Scenario
- 7.4.9.5. Norway Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.2. Japan
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Scenario
- 7.5.2.4. Reimbursement Scenario
- 7.5.2.5. Japan Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.3. China
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Scenario
- 7.5.3.4. Reimbursement Scenario
- 7.5.3.5. China Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory Scenario
- 7.5.4.4. Reimbursement Scenario
- 7.5.4.5. India Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.5. South Korea
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Competitive Scenario
- 7.5.5.3. Regulatory Scenario
- 7.5.5.4. Reimbursement Scenario
- 7.5.5.5. South Korea Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.6. Australia
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Competitive Scenario
- 7.5.6.3. Regulatory Scenario
- 7.5.6.4. Reimbursement Scenario
- 7.5.6.5. Australia Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.7. Thailand
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Competitive Scenario
- 7.5.7.3. Regulatory Scenario
- 7.5.7.4. Reimbursement Scenario
- 7.5.7.5. Thailand Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6. Latin America
- 7.6.1. Latin America Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Scenario
- 7.6.2.4. Reimbursement Scenario
- 7.6.2.5. Brazil Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Scenario
- 7.6.3.4. Reimbursement Scenario
- 7.6.3.5. Argentina Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7. Middle East & Africa
- 7.7.1. Middle East & Africa Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Scenario
- 7.7.2.4. Reimbursement Scenario
- 7.7.2.5. South Africa Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.3. Saudi Arabia
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Scenario
- 7.7.3.4. Reimbursement Scenario
- 7.7.3.5. Saudi Arabia Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory Scenario
- 7.7.4.4. Reimbursement Scenario
- 7.7.4.5. UAE Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory Scenario
- 7.7.5.4. Reimbursement Scenario
- 7.7.5.5. Kuwait Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Market Participant Categorization
- 8.2. Key Company Profiles
- 8.2.1. Essity Aktiebolag (publ).
- 8.2.1.1. Company Overview
- 8.2.1.2. Financial Performance
- 8.2.1.3. Service Benchmarking
- 8.2.1.4. Strategic Initiatives
- 8.2.2. Cardinal Health
- 8.2.2.1. Company Overview
- 8.2.2.2. Financial Performance
- 8.2.2.3. Service Benchmarking
- 8.2.2.4. Strategic Initiatives
- 8.2.3. Julius Zorn GmbH
- 8.2.3.1. Company Overview
- 8.2.3.2. Financial Performance
- 8.2.3.3. Product Benchmarking
- 8.2.3.4. Strategic Initiatives
- 8.2.4. Hartmann AG
- 8.2.4.1. Company Overview
- 8.2.4.2. Financial Performance
- 8.2.4.3. Product Benchmarking
- 8.2.4.4. Strategic Initiatives
- 8.2.5. Medi GmbH & Co.
- 8.2.5.1. Company Overview
- 8.2.5.2. Financial Performance
- 8.2.5.3. Product Benchmarking
- 8.2.5.4. Strategic Initiatives
- 8.2.6. SIGVARIS
- 8.2.6.1. Company Overview
- 8.2.6.2. Financial Performance
- 8.2.6.3. Product Benchmarking
- 8.2.6.4. Strategic Initiatives
- 8.2.7. ArjoHuntleigh
- 8.2.7.1. Company Overview
- 8.2.7.2. Financial Performance
- 8.2.7.3. Product Benchmarking
- 8.2.7.4. Strategic Initiatives
- 8.2.8. 3M
- 8.2.8.1. Company Overview
- 8.2.8.2. Financial Performance
- 8.2.8.3. Product Benchmarking
- 8.2.8.4. Strategic Initiatives
- 8.2.9. Spectrum Healthcare
- 8.2.9.1. Company Overview
- 8.2.9.2. Financial Performance
- 8.2.9.3. Product Benchmarking
- 8.2.9.4. Strategic Initiatives
- 8.2.10. Bio Compression Systems, Inc.
- 8.2.10.1. Company Overview
- 8.2.10.2. Financial Performance
- 8.2.10.3. Product Benchmarking
- 8.2.10.4. Strategic Initiatives
- 8.2.11. Stryker
- 8.2.11.1. Company Overview
- 8.2.11.2. Financial Performance
- 8.2.11.3. Product Benchmarking
- 8.2.11.4. Strategic Initiatives
- 8.2.12. Gottfried Medical
- 8.2.12.1. Company Overview
- 8.2.12.2. Financial Performance
- 8.2.12.3. Product Benchmarking
- 8.2.12.4. Strategic Initiatives
- 8.2.13. Tactile Medical
- 8.2.13.1. Company Overview
- 8.2.13.2. Financial Performance
- 8.2.13.3. Product Benchmarking
- 8.2.13.4. Strategic Initiatives
- 8.3. Heat Map Analysis/ Company Market Position Analysis
- 8.4. Estimated Company Market Share Analysis, 2025
- 8.5. List of Other Key Market Players